OSTRUM ASSET MANAGEMENT

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1767945 PARIS, I0

Position in ALNY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$538,241

+$220,275 QoQ

Shares Held

1,788

+86.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#472

of 780 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OSTRUM ASSET MANAGEMENT holds $8,656,924 across 7 Biotechnology names. ALNY ranks #5 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	99,352	$5,570,666
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,403	$696,912
3	INCY	Incyte Corp	5,280	$598,540
4	REGN	Regeneron Pharmaceuticals, Inc.	920	$573,656
5	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,788	$538,241
6	INSM	INSMED Inc	3,385	$360,908
7	RVMD	Revolution Medicines, Inc.	1,698	$318,001

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$538,241	1,788	+86.1%	Shares	Defined	2026-08-13
2026-03-31	$317,966	961	+1.5%	Shares	Defined	2026-05-14
2025-12-31	$376,574	947	+148.6%	Shares	Defined	2026-02-13
2025-09-30	$173,736	381	-3.3%	Shares	Defined	2025-11-14
2025-06-30	$128,479	394	-3.0%	Shares	Defined	2025-08-13
2025-03-31	$109,628	406	-2.6%	Shares	Defined	2025-05-14
2024-12-31	$98,124	417	-90.5%	Shares	Defined	2025-02-13
2024-09-30	$1,210,957	4,403	-23.3%	Shares	Defined	2024-11-13
2024-06-30	$1,395,306	5,742	-7.2%	Shares	Defined	2024-08-13
2024-03-31	$924,946	6,189	0.0%	Shares	Defined	2024-05-13
2023-12-31	$1,184,636	6,189	+1260.2%	Shares	Defined	2024-02-13
2023-09-30	$80,580	455	-0.9%	Shares	Defined	2023-11-14
2023-06-30	$87,182	459	+0.2%	Shares	Defined	2023-08-11
2023-03-31	$91,746	458	—	Shares	Defined	2023-05-12
No filing history on record for this holder in this stock.